Qube Research & Technologies LTD Mannkind Corp Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Mannkind Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,126,388 shares of MNKD stock, worth $7.59 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,126,388
Previous 155,042
626.51%
Holding current value
$7.59 Million
Previous $809,000
774.29%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MNKD
# of Institutions
244Shares Held
148MCall Options Held
1.62MPut Options Held
802K-
Black Rock Inc. New York, NY22.6MShares$152 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.6MShares$105 Million0.0% of portfolio
-
State Street Corp Boston, MA9.6MShares$64.7 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY9.16MShares$61.7 Million6.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$59 Million0.83% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.73B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...